|
||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Imperial Cancer Research Fund, Clare Hall Laboratories, South Mimms, Potters Bar, Herts EN6 3LD, United Kingdom
The replication licensing factor (RLF) is an
essential initiation factor that is involved in preventing
re-replication of chromosomal DNA in a single cell cycle. In Xenopus egg extracts, it can be separated into
two components: RLF-M, a complex of MCM/P1 polypeptides, and RLF-B, which is currently unpurified. In this paper we investigate variations in RLF activity throughout the cell cycle. Total RLF activity is
low in metaphase, due to a lack of RLF-B activity and
the presence of an RLF inhibitor. RLF-B is rapidly activated on exit from metaphase, and then declines during
interphase. The RLF inhibitor present in metaphase extracts is dependent on the activity of cyclin-dependent
kinases (Cdks). Affinity depletion of Cdks from
metaphase extracts removed the RLF inhibitor, while
Cdc2/cyclin B directly inhibited RLF activity. In
metaphase extracts treated with the protein kinase inhibitor 6-dimethylaminopurine (6-DMAP), both cyclin
B and the RLF inhibitor were stabilized although the
extracts morphologically entered interphase. These results are consistent with studies in other organisms that
invoke a key role for Cdks in preventing re-replication of DNA in a single cell cycle.
This article has been cited by other articles:
|
|